← All indications
Adenoma, Islet Cell
A benign tumor of the pancreatic ISLET CELLS. Usually it involves the INSULIN-producing PANCREATIC BETA CELLS, as in INSULINOMA, resulting in HYPERINSULINISM.
Subtype terms (1)
More specific conditions that are subtypes of Adenoma, Islet Cell in the MeSH hierarchy.
- Insulinoma
22 drugs (15 approved, 7 experimental)
Drugs by status
Approved for this indication (1)
Phase 3 trials (4)
Phase 2 trials (15)
Phase 1 trials (1)
Organizations
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (7)
Organization Involved with Phase 2 Indications (22)
- Amgen
- Schering-Plough
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- University of London
- Cornell University
- Harvard University
- Eastern Cooperative Oncology Group
- ECOG-ACRIN Cancer Research Group
- Grupo Espanol de Tumores Neuroendocrinos (GETNE)
- Istituto Nazionale per lo Studio e la Cura dei Tumori
- Northwestern University
- Ochsner Health System
- Ohio State University
- University of Milan
- University of South Florida
- University of Cambridge
- Vanderbilt University
- Tsinghua University
- University of Texas at Houston
- University of Paris
- Chinese Academy of Medical Sciences
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (1)